Alpha Teknova Inc
NASDAQ:TKNO

Watchlist Manager
Alpha Teknova Inc Logo
Alpha Teknova Inc
NASDAQ:TKNO
Watchlist
Price: 8.6 USD 11.98% Market Closed
Market Cap: 458.5m USD
Have any thoughts about
Alpha Teknova Inc?
Write Note

Alpha Teknova Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Alpha Teknova Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Alpha Teknova Inc
NASDAQ:TKNO
Accrued Liabilities
$6.3m
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Accrued Liabilities
$5.2B
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
12%
Danaher Corp
NYSE:DHR
Accrued Liabilities
$2.9B
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
1%
Mettler-Toledo International Inc
NYSE:MTD
Accrued Liabilities
$364.6m
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Accrued Liabilities
$766m
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
4%
IQVIA Holdings Inc
NYSE:IQV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Alpha Teknova Inc
Glance View

Market Cap
458.4m USD
Industry
Life Sciences Tools & Services

Alpha Teknova, Inc. manufactures cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 231 full-time employees. The company went IPO on 2021-06-25. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions. Its processes enable it to manufacture and deliver custom, made-to-order products across all stages of development, including commercialization. The firm's processes are designed to handle as array of customer-requested inputs, which vary by volume, chemical formulation, quality specifications, container types, and transportation requirements, enabling use of its products across the scope of the life sciences market.

TKNO Intrinsic Value
2.57 USD
Overvaluation 70%
Intrinsic Value
Price

See Also

What is Alpha Teknova Inc's Accrued Liabilities?
Accrued Liabilities
6.3m USD

Based on the financial report for Dec 31, 2023, Alpha Teknova Inc's Accrued Liabilities amounts to 6.3m USD.

What is Alpha Teknova Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
40%

Over the last year, the Accrued Liabilities growth was -23%. The average annual Accrued Liabilities growth rates for Alpha Teknova Inc have been 40% over the past three years .

Back to Top